Caris Life Sciences (CAI) Change in Inventory (2024 - 2026)
Caris Life Sciences (CAI) recorded quarterly Change in Inventory of $13.3 million in Q1 2026, up 38.75% quarter-over-quarter from $9.6 million in Q4 2025, and up 746.68% on a YoY basis from $1.6 million in Q1 2025.
Caris Life Sciences (CAI) Change in Inventory (2024 - 2026) Analysis & Trends
Caris Life Sciences' Change in Inventory history runs 3 years deep, the most recent figure standing at $13.3 million for Q1 2026.
- In Q1 2026, Change in Inventory rose 746.68% year-over-year to $13.3 million; the TTM figure through Mar 2026 stood at $36.1 million (changed N/A YoY), while the FY2025 annual figure was $20.8 million, up 480.11% from the prior year.
- Change in Inventory was $13.3 million for Q1 2026 at Caris Life Sciences, up from $9.6 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $13.3 million in Q1 2026 to a low of -$2.1 million in Q1 2025.
- Historically, Change in Inventory has averaged $5.2 million across 3 years, with a median of $4.7 million in 2025.
- Biggest YoY gain for Change in Inventory was 869.71% in 2025; the steepest drop was 158.82% in 2025.
- A 3-year view of Change in Inventory shows it stood at -$1.2 million in 2024, then jumped by 869.71% to $9.6 million in 2025, then surged by 38.75% to $13.3 million in 2026.
- The last three Change in Inventory figures came in at $13.3 million (Q1 2026), $9.6 million (Q4 2025), and $8.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Caris Life Sciences | 5.22 Bn | 4.40 Bn | 171.13 Mn | 13.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.33 Mn |
| Mar 31, 2026 | 13.33 Mn |
| Dec 31, 2025 | 9.61 Mn |
| Dec 31, 2025 | 9.61 Mn |
| Sep 30, 2025 | 8.52 Mn |
| Sep 30, 2025 | 8.52 Mn |
| Jun 30, 2025 | 4.68 Mn |
| Jun 30, 2025 | 4.68 Mn |
| Mar 31, 2025 | -2.06 Mn |
| Mar 31, 2025 | -2.06 Mn |
| Dec 31, 2024 | -1.25 Mn |
| Dec 31, 2024 | -1.25 Mn |
| Sep 30, 2024 | 3.29 Mn |
| Sep 30, 2024 | 3.29 Mn |